Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
- 11 October 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet HIV
- Vol. 6 (12), e821-e830
- https://doi.org/10.1016/s2352-3018(19)30338-8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (grant U01 AI115711)
- Intramural Research Program of the National Institute of Health
- National Cancer Institute, and the Nutrition Obesity Research Center at Harvard (grant P30 DK040561, 1UL1TR002541-01, 1UL1TR001102)
- National Cancer Institute
- National Institutes of Health (HHSN261200800001E)
This publication has 30 references indexed in Scilit:
- Hydrogen-1 MR Spectroscopy for Measurement and Diagnosis of Hepatic SteatosisAmerican Journal of Roentgenology, 2012
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of GastroenterologyGastroenterology, 2012
- Reduction in Visceral Adiposity Is Associated With an Improved Metabolic Profile in HIV-Infected Patients Receiving TesamorelinClinical Infectious Diseases, 2012
- Effects of a Growth Hormone-Releasing Hormone Analog on Endogenous GH Pulsatility and Insulin Sensitivity in Healthy MenJournal of Clinical Endocrinology & Metabolism, 2011
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- The Effects of Central Adiposity on Growth Hormone (GH) Response to GH-Releasing Hormone-Arginine Stimulation Testing in MenJournal of Clinical Endocrinology & Metabolism, 2008
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and PredictorsClinical Infectious Diseases, 2008
- Visceral fat: A key mediator of steatohepatitis in metabolic liver diseaseHepatology, 2008
- Metabolic Effects of a Growth Hormone–Releasing Factor in Patients with HIVNew England Journal of Medicine, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005